U.S. Insurance Stock News

Applied Optoelectronics recently reported its second quarter 2025 results, revealing a sharp increase in sales to US$102.95 million and a significantly smaller net loss of US$9.1 million compared to the previous year, while also announcing a new three-year US$35 million credit facility and projecting third quarter revenue between US$115 million and US$127 million. An important insight is that the company’s combination of higher revenues, reduced losses, and bolstered financial flexibility...

NCR Atleos Corporation recently reported higher net income and earnings per share for the second quarter of 2025, announced a new US$200 million share repurchase program, reaffirmed its 2025 guidance, and revealed expanded ATM partnerships with FCTI Inc. and Casey's. The FCTI collaboration points to one of the largest single service endpoint ATM deployments in the U.S. market, underscoring NCR Atleos' expanding reach in self-service financial solutions. We'll explore how the substantial...

10x Genomics, Inc. reported second quarter 2025 earnings earlier this month, posting revenue of US$172.91 million and a return to net profitability compared with a net loss in the same period last year. The company noted that its revenue guidance for the upcoming quarter reflects accelerated purchases from customers in China anticipating possible tariff changes, highlighting how regulatory factors can shift demand and impact reported results. We'll explore how 10x Genomics's return to...

APi Group recently reported strong results, highlighted by robust organic revenue and adjusted EBITDA growth in its core Safety Services segment, alongside upward full-year earnings estimate revisions and increased institutional interest. This momentum underscores the impact of heightened safety regulations and expanding recurring revenue on the company's market enthusiasm and operational performance. Next, we’ll examine how the positive shift in earnings outlook may influence APi Group’s...

Earlier this month, CoStar Group extended its legal battle by filing a copyright infringement lawsuit against Zillow, alleging unauthorized use and distribution of over 46,000 copyrighted images and seeking damages potentially exceeding US$1 billion. This development highlights ongoing competitive and legal tensions within the digital real estate marketplace, raising complex questions about intellectual property protection and industry relationships. We'll explore how investor concerns...

Blue Bird Corporation recently announced the delivery of 25 electric school buses to the Little Rock School District in Arkansas, marking a significant step in school transportation electrification backed by nearly US$9.88 million in EPA funding. This milestone adds to Blue Bird’s position as the only U.S.-owned school bus maker and strengthens its leadership with over 2,500 electric buses in operation nationwide. We'll explore how Blue Bird's $100 million buyback plan and major EV contract...

Earlier this month, Xometry reported second quarter 2025 results with revenue of US$162.55 million, up from US$132.6 million a year earlier, while net loss widened to US$26.43 million and the company provided third-quarter and full-year earnings guidance, including raised marketplace growth expectations to 23-24% for 2025. While core marketplace revenues are accelerating, the company expects supplier services revenue to decline approximately 5% year-over-year, indicating a changing mix in...

Warby Parker recently announced second-quarter 2025 earnings, reporting US$214.48 million in sales and a significant reduction in net loss compared to the previous year, alongside an increase in full-year revenue guidance and plans for 45 new store openings, including Target shop-in-shops. In addition to financial gains and positive outlook, the company is experiencing an executive transition, with Co-Founder and Co-CEO Dave Gilboa stepping in as interim principal financial officer following...

Root, Inc. recently reported second quarter 2025 results, announcing a net income of US$20.9 million, a turnaround from a net loss of US$7.8 million in the prior year, and improved earnings per share from both basic and diluted continuing operations. This marks the company's first return to profitability for both the quarter and year-to-date periods, reflecting a substantial shift in operating performance. We will examine how Root's return to profitability could influence its ongoing...

Sensient Technologies recently participated in Baird's Investor Day in St. Louis and held a special company call, both events taking place earlier this week. These activities have raised expectations among investors for potential new disclosures or updates that could signal meaningful shifts in the company's direction. We'll explore how Sensient's investor conference participation and special call may influence its outlook for natural colors and clean-label growth. We've found 19 US stocks...

Gibraltar Industries recently announced its second-quarter 2025 results, reporting increased sales of US$309.52 million but a decrease in net income to US$26 million compared to the previous year, along with updated full-year guidance projecting lower earnings per share for 2025. While sales growth continued, the company's forecast for reduced annual earnings per share compared to 2024 signals shifting profitability dynamics that may influence expectations for the rest of the year. We'll now...

Arrowhead Pharmaceuticals announced its third quarter and nine-month results for the period ended June 30, 2025, reporting US$27.77 million in quarterly sales and a net loss of US$175.24 million for the quarter, but a shift to net income of US$22.12 million for the nine months, compared to a loss of US$428.96 million a year earlier. This turnaround was driven by a very large year-on-year increase in year-to-date sales, resulting in the company returning to profitability over the nine-month...

In recent weeks, Vertex Pharmaceuticals reported strong second-quarter financial results with US$2.96 billion in revenue and announced its investigational pain therapy VX-993 did not meet the primary endpoint in a Phase 2 trial, resulting in the decision not to pursue it further as a monotherapy for acute pain. This combination of a pipeline setback and robust financial performance, alongside continued share repurchases and confirmation of annual revenue guidance, reflects both the strengths...

Earlier this month, Surgery Partners reported second-quarter 2025 results with sales rising to US$826.2 million and a significantly lower net loss compared to the previous year, while reaffirming its full-year revenue guidance of US$3.3 billion to US$3.45 billion; the company also announced Wayne S. DeVeydt’s immediate resignation as Executive Chairman and director, appointing Blair E. Hendrix as the new Board Chairman and reducing the Board size to 10 directors. Despite the leadership...

Supernus Pharmaceuticals recently reported its second-quarter 2025 earnings, showing year-over-year revenue of US$165.45 million and net income of US$22.5 million, alongside updated full-year guidance reflecting anticipated revenue of US$670 million to US$700 million due to strong first-half results and the Sage acquisition. While quarterly revenue declined slightly from the prior year, improved profitability and the upward revision in annual guidance highlight a significant shift in...

Arcellx, Inc. recently reported its second quarter 2025 earnings, disclosing a net loss of US$52.77 million, up from US$27.2 million in the same period last year, and a basic loss per share of US$0.94 versus US$0.51 year-over-year. This sharp increase in net loss highlights considerable changes in the company's cost structure or spending priorities compared to previous periods. We'll examine how Arcellx's significantly higher net losses this quarter influence its investment narrative and...

ZoomInfo Technologies recently reported improved second quarter results with US$306.7 million in sales, returning to profitability and raising full-year revenue guidance to a range of US$1.215–1.225 billion, up from prior expectations. Along with completing a major share repurchase and appointing Michael Graham O’Brien as Chief Financial Officer, these developments highlight management’s confidence and a focus on operational discipline. We'll explore how the upgraded revenue outlook and...

The Kroger Co. recently announced it has reached a confidential settlement with C&S Wholesale Grocers, LLC, resolving all claims in their previously pending litigation before the Superior Court for the State of Delaware. This settlement closes a chapter of legal uncertainty for Kroger, potentially clearing the way for clearer operational and financial planning moving forward. Let's explore how resolving this significant legal dispute may influence Kroger's investment narrative and outlook...

WeRide recently secured regulatory approval to conduct late-night Robotaxi testing on public roads in Beijing, allowing operations from 10pm to 7am as part of its drive toward a 24/7 autonomous ride-hailing network. This milestone showcases WeRide's technological strengths in addressing complex, real-world challenges like low-light and harsh weather, strengthening its position in autonomous mobility innovation. We'll look at how WeRide's expanded Robotaxi testing in Beijing reinforces its...

In August 2025, Rosen Law Firm began investigating potential securities claims against GeneDx Holdings Corp. following allegations that the company issued misleading business information and was accused of fraudulent revenue inflation involving Medicaid and Medicare systems. This legal scrutiny and preparation for a class action lawsuit highlight serious questions about GeneDx’s financial reporting practices and increase the company's exposure to legal and reputational risk. We’ll examine...

Urban Edge Properties recently completed a follow-on equity offering totaling US$250 million and filed a shelf registration to enable the issuance of additional securities, including common and preferred shares as well as debt instruments. This move greatly enhances the company’s financial flexibility, equipping it with fresh capital for future acquisitions, development projects, or potential debt reduction initiatives. We'll examine how the expanded capital base from the equity offering...

Charles River Laboratories International recently announced its second quarter 2025 results, reporting revenue of US$1.03 billion and net income of US$52.33 million, both nearly flat or lower compared to the previous year, and updated its full-year outlook to reflect a smaller projected revenue decline. The company’s revised guidance, showing a softer fall in revenue and confirmation of earnings estimates, may indicate some stabilization in business conditions despite ongoing margin...

NasdaqGM:LNTH 1 Year Share Price vs Fair Value Explore Lantheus Holdings's Fair Values from the Community and select...

CSP ( NASDAQ:CSPI ) Third Quarter 2025 Results Key Financial Results Revenue: US$15.4m (up 18% from 3Q 2024). Net loss...